Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients

14 Aug 2012

Abstract excerpt

BACKGROUND: MicroRNAs are proposed as plasma biomarkers in cancer. Glioblastoma is the most frequent primary brain tumor of adults. MicroRNA-21 was shown to induce glioblastoma growth. AIMS: To evaluate the circulating microRNA-21 in glioblastoma patients. METHODS: MicroRNA-21 copies in glioblastoma plasma (n = 10, before surgery and during/after concomitant chemoradiotherapy), control plasma (n = 10), and tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22891879
DOI: 10.3109/07357907.2012.708071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma PatientsPMID 22891879Read ↗

Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosisSemantic proximity Read ↗

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and SerumSemantic proximity Read ↗

miR-21 as a Diagnostic and Prognostic Biomarker in Glioma: Tissue and Serum Expression Analysis in a Pakistani CohortSemantic proximity Read ↗

Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiformSemantic proximity Read ↗

Targeting miR-21 in glioma: a small RNA with big potentialSemantic proximity Read ↗

Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in GliomaSemantic proximity Read ↗

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomasSemantic proximity Read ↗

Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs.Semantic proximity Read ↗

MiRNA-181d Expression Correlates in Tumor versus Plasma of Glioblastoma Patients—the Base of a Preoperative Stratification Tool for Local Carmustine Wafer UseSemantic proximity Read ↗

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patientsSemantic proximity Read ↗

Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.Semantic proximity Read ↗

Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese FemalesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.